

The Chairman of Greggs, the FTSE 250 baking group, on Thursday purchased 2,500 shares just a few days after the company warned investors profits are l...


AIM-listed pharmaceutical products and services business Clinigen Group has acquired Cardioxane (dexrazoxane) from Novartis for 33m dollars in cash, p...


Abbey Protection: Numis downgrades to hold with its target price at 120p. Aberdeen Asset Management: Bank of America raises target price from 425p to...


Admiral Group: Berenberg ups target price from 1000p to 1060p, but still recommends selling. Amlin: Westhouse Securities raises target price from 440...


Clinigen, the speciality pharmaceuticals company which listed on the AIM market last autumn, saw shares surge on Wednesday after the firm reported a m...